[Why ribonucleases cause death of cancer cells]

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Context:

• Cytotoxic ribonucleases (RNases) are emerging as promising antitumor therapeutics.
• Understanding their precise mechanisms of action is crucial for optimizing their clinical application.

Purpose:

• To characterize the molecular properties and mechanisms of action of cytotoxic RNases.
• To identify cellular components and molecular determinants responsible for selective antitumor activity.
• To elucidate the role of RNase charge, catalytic activity, and non-catalytic interactions in cancer cell death.

Summary:

• RNase cytotoxicity is significantly influenced by the enzyme's molecular charge.
• Cytotoxic effects result from both catalytic RNA cleavage and non-catalytic electrostatic interactions with cellular components.
• Potential targets within cancer cells include RNA, calcium-dependent potassium channels, and ras-oncogene pathways.
• RNases can modulate gene expression through interference with RNA interference pathways.

Impact:

• Provides insights into the selective targeting of malignant cells by exogenous RNases.
• Defines key molecular determinants contributing to RNase-induced cytotoxicity.
• Highlights potential therapeutic strategies for cancer treatment using engineered RNases.
• Suggests novel mechanisms by which RNases influence cancer cell biology and gene expression.